Butyrate-mediated changes of colon cancer cell sensitivity to TNF-α have been associated with the modulation of NF-κB activity, which had a significant impact on proliferation, apoptosis, and inflammation in colon cancer cells. Here, NFKB1 is linked to colonic neoplasm.